PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 1, 1996Circulation433 citations

Extracellular Potassium Modulation of Drug Block of IKr

View Full Paper
TYTao YangDRDan M. Roden

Key Result

Elevating extracellular potassium from 1 to 8 mmol/L increased the IC50 for dofetilide block from 2.7 to 79 nmol/L and for quinidine block from 0.4 to 3.8 mumol/L.

Structured PICO

Does changing extracellular potassium modulate the block of IKr by quinidine and dofetilide in AT-1 cells?

P
Population
AT-1 cells
I
Intervention
Changing extracellular potassium ([K+]o) from 1 to 8 mmol/L in the presence of quinidine or dofetilide
C
Comparator
Different concentrations of extracellular potassium
O
Outcome
Drug concentration producing 50% inhibition of IKr tails (IC50)surrogate

Low extracellular potassium increases drug block of IKr, providing a mechanistic link between hypokalemia and torsade de pointes.

Abstract

BACKGROUND: Torsade de pointes often occurs with underlying hypokalemia and bradycardia. A common effect of many drugs producing torsade de pointes is block of the rapidly activating component of the cardiac delayed rectifier (IKr). In this study, we evaluated the effect of changing extracellular potassium (K+o) on IKr block by the nonspecific agent quinidine and by the specific IKr blocker dofetilide. METHODS AND RESULTS: IKr was measured in AT-1 cells, where contaminating outward currents are absent. The drug concentration producing 50% inhibition of IKr tails (IC50) was strikingly K+o-dependent. Elevating K+o from 1 to 8 mmol/L increased the IC50 for dofetilide block from 2.7 +/- 0.9 to 79 +/- 32 nmol/L and for quinidine block from 0.4 +/- 0.1 to 3.8 +/- 1.2 mumol/L. CONCLUSIONS: (1) The increase in drug block with low K+o provides a mechanism to explain the link between hypokalemia and torsade de pointes. (2) Elevations in K+o occur with myocardial ischemia and with rapid pacing. Possible consequences of blunted drug block with high K+o include loss of drug efficacy with ischemia and with rapid pacing; the latter may contribute to "reverse use-dependent" action potential prolongation. Extracellular potassium is a critical determinant of drug block of IKr, with substantial clinical implications.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yang et al. (1996) studied Torsade de pointes. Extracellular potassium ([K+]o) modulation was evaluated on Drug concentration producing 50% inhibition of IKr tails (IC50). Elevating extracellular potassium from 1 to 8 mmol/L increased the IC50 for dofetilide block from 2.7 to 79 nmol/L and for quinidine block from 0.4 to 3.8 mumol/L.

synapsesocial.com/papers/6a131337b761793c20c1144fhttps://doi.org/10.1161/01.cir.93.3.407
Ask AI
Helpful
Bookmark
Share
View Full Paper